Kincell Bio

Executive Summary

Kincell Bio is a contract development and manufacturing organization (CDMO) specializing in cell and gene therapies, headquartered in Durham, North Carolina, with an additional facility in Gainesville, Florida. Founded in 2018, the company offers comprehensive CMC services including analytical and process development, as well as GMP manufacturing, supporting clients from early clinical stages through commercial launch. As the cell and gene therapy market expands, Kincell Bio is well-positioned to benefit from increased outsourcing demand. The company's strategic focus on end-to-end services and its dual-facility footprint enhance its ability to serve a diverse client base. While private financial details are limited, the CDMO sector generally enjoys strong tailwinds from the growing pipeline of advanced therapies.

Upcoming Catalysts (preview)

• Q3 2026Announcement of new or expanded GMP manufacturing capacity50% success
• TBDStrategic partnership with a major cell therapy developer35% success
• Q4 2026Completion of FDA pre-approval inspection for a client's product40% success